Definitive Contract 75F40120C00061
Award Date 9/4/20
Potential Completion Date 9/14/25
Potential Value $693K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Children's Hospital of Philadelphia (CHOP) has been awarded a Definitive Contract by the Food and Drug Administration (FDA) for $1,048,942.00 to conduct research and development on drug development for pediatric cancers. The contract is a renewal of the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which seeks proposals across areas of regulatory science to modernize research and support the FDA's mission. The contract has no set-aside designation. As a leading...
- The U.S. Food and Drug Administration (FDA) awarded a $87,181 firm-fixed-price purchase order contract to The Children's Hospital of Philadelphia (CHOP) to study the "Natural History of Enteroviral Sepsis Using Real World Data". The contract has an ultimate completion date of August 31, 2023. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas such as infectious diseases to contribute to this federal healthcare initiative. The contract does...
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) for a project titled "Metagenomics and Metabolomics of the SIT Study". The contract has a total ceiling value of $96,865.90 and a completion date of August 17, 2024. The contract is not set aside for any particular business type. As a leading pediatric...
- This is a $135,193.73 firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP). The contract, which does not have a set-aside designation, is for research services related to pediatric diseases and conditions, including genetic diseases, pediatric cancer, and mitochondrial disorders. CHOP, a nonprofit pediatric hospital and research center, has provided research...
- This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to The Children's Hospital of Philadelphia (CHOP) Research Institute on September 30, 2017 for a value of $322,263.00. The contract does not have a set-aside designation and is for the performance of "OTHER FUNCTIONS" with a completion date of June 30, 2019. CHOP is a pediatric healthcare provider, research institution, and...
- This is a federal contract award to The Children's Hospital of Philadelphia (CHOP) from the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services. The $18,779,641.25 definitive contract is for research and development facilities, with a period of performance ending on March 31, 2010. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, is the prime...
- The U.S. government agency has awarded a Firm Fixed Price Purchase Order contract to The Children's Hospital of Philadelphia (CHOP) for $20,313.70. The contract, which has no set-aside designation, is for SEQUENCING AND ANALYSIS services, including analysis reference estimates. CHOP, a leading pediatric hospital and research facility, has been awarded this contract to leverage its expertise in areas such as pediatric cancers, rare diseases, genetic disorders, neurodevelopmental conditions, and...
- This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to The Children's Hospital of Philadelphia (CHOP) on September 29, 2020. The $347,335.00 contract is for research on the incidence and outcomes of human adenovirus infection and disease among a multicenter observational cohort of pediatric allogeneic hematopoietic cell transplant recipients. The contract has a completion date of September 29, 2023 and does not have a...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to The Children's Hospital of Philadelphia (CHOP) for data analysis and reporting services. The contract has a ceiling value of $149,998.95 and a period of performance through December 28, 2017. The contract does not have a set-aside designation. As a leading pediatric research institution, CHOP has been awarded numerous federal contracts and grants from agencies such as the Department of...
- This is a $276,916.98 federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, which is a definitive contract with cost-no-fee pricing, is for the National Children's Study. The contract does not have a set-aside designation. As a leading pediatric hospital and research institution, CHOP leverages...